Skip to content
★ Sign in to follow
PP

Pamela P. Palmer

Directeur Médical
Total declarations
28
Company
1
▲ Purchases (5 ops.)
€186k
▼ Sales (2 ops.)
€18k

Latest filing published 04 Mar 2024 for TALPHERA, INC., €541.

Filing timeline

BuySale
Pamela P. Palmer

Insider track record

Disclosed buys
5
Disclosed sells
2
Signal history

Closed purchases

Market purchases
5
Positive at T+90
20%
Median T+90
-25.9%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 04 Mar 2019 · 2807 days ago · €2,074
    -60.6%
    Entry US$74.60 · Close at T+365 US$29.40
  • Filed 19 Nov 2018 · 2912 days ago · €43k
    -50.1%
    Entry US$67.80 · Close at T+365 US$33.80
  • Filed 06 Aug 2018 · 3017 days ago · €88k
    -17.9%
    Entry US$57.00 · Close at T+365 US$46.80
  • Filed 22 Aug 2017 · 3366 days ago · €25k
    -1.7%
    Entry US$60.00 · Close at T+365 US$59.00
  • Filed 13 Jun 2011 · 5628 days ago · €28k
    -31.4%
    Entry US$91.80 · Close at T+365 US$63.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Pamela P. Palmer: trading record in brief

All filings by Pamela P. Palmer on record concern Talphera, Inc., in the capacity of senior executive. In total, 28 filings cover trades dated from 2 March 2011 to 3 March 2024.

In open-market terms, that means 5 purchases worth €186k on one side and 2 sales worth €18k on the other. The net balance comes to €168k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 19 share grants and 2 option exercises.

In size, the median ticket on the buying side is €28k. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 5 purchases show a median change of -25.9%, with the price up in 20% of them. Past outcomes like these are no guarantee of what comes next.

Most recently, on 4 March 2024, the filings show a share grant worth €541 in Talphera, Inc. The last insider purchase was made public on 4 March 2019, 2,807 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Pamela P. Palmer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    585 USD15SEC
    450 shares@ US$1.3039.8% of flowCommon StockSEC:0001209191-24-004245:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    0SEC
    18,000 shares0Common StockSEC:0001209191-24-004045:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    881 USD11SEC
    801 shares@ US$1.100.3% of flowCommon StockSEC:0001209191-24-003307:1
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    881 USD17SEC
    801 shares@ US$1.1060.2% of flowCommon StockSEC:0001209191-24-003307:0
  • ▼
    Chief Medical OfficerExecutivesTalphera, Inc.
    8,112 USD11SEC
    7,442 shares@ US$1.093.1% of flowCommon StockSEC:0001209191-23-047348:1
  • ▼
    Chief Medical OfficerExecutivesTalphera, Inc.
    11,131 USD16SEC
    9,514 shares@ US$1.1750.7% of flowCommon StockSEC:0001209191-23-047348:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    747 USD11SEC
    570 shares@ US$1.313.5% of flowCommon StockSEC:0001209191-23-016324:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    1,709 USD12SEC
    1,017 shares@ US$1.687.8% of flowCommon StockSEC:0001209191-23-009131:1
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    0SEC
    6,125 shares0Common StockSEC:0001209191-23-009131:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    1,376 USD12SEC
    681 shares@ US$2.026.3% of flowCommon StockSEC:0001209191-23-007816:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    3,223 USD12SEC
    7,923 shares@ US$0.406814.3% of flowCommon StockSEC:0001209191-22-016251:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    3,182 USD11SEC
    7,927 shares@ US$0.40141.1% of flowCommon StockSEC:0001209191-22-009353:1
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    0SEC
    122,500 shares0Common StockSEC:0001209191-22-009353:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    4,049 USD13SEC
    9,391 shares@ US$0.431217.4% of flowCommon StockSEC:0001209191-22-007635:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    0SEC
    68,750 shares0Common StockSEC:0001209191-21-018155:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    23,446 USD12SEC
    8,915 shares@ US$2.638.3% of flowCommon StockSEC:0001209191-21-010350:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    24,382 USD12SEC
    9,414 shares@ US$2.598.8% of flowCommon StockSEC:0001209191-21-008811:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    13,550 USD15SEC
    7,924 shares@ US$1.7136.4% of flowCommon StockSEC:0001209191-20-009163:0
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    0SEC
    68,750 shares0Common StockSEC:0001209191-20-007742:0
  • ▲
    Chief Medical OfficerExecutivesTalphera, Inc.
    2,360 USD33SEC
    840 shares@ US$2.811.2% of flowCommon StockSEC:0001209191-19-015612:0
    Canonical exit: 29 May 2019 (T+90)
  • ◆
    Chief Medical OfficerExecutivesTalphera, Inc.
    0SEC
    68,750 shares0Common StockSEC:0001209191-19-009812:0
  • ▲
    Chief Medical OfficerExecutivesTalphera, Inc.
    49,120 USD31SEC
    16,000 shares@ US$3.0725.7% of flowCommon StockSEC:0001209191-18-059292:0
    Canonical exit: 17 Feb 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesTalphera, Inc.
    101,750 USD28SEC
    37,000 shares@ US$2.7552.6% of flowCommon StockSEC:0001209191-18-045581:0
    Canonical exit: 4 Nov 2018 (T+90)
  • ▲
    Chief Medical OfficerExecutivesTalphera, Inc.
    29,500 USD12SEC
    10,000 shares@ US$2.9513.0% of flowCommon StockSEC:0001437749-17-015179:0
    Canonical exit: 20 Nov 2017 (T+90)
  • ◇
    Chief Medical OfficerExecutivesTalphera, Inc.
    74,240 USD0SEC
    29,000 shares@ US$2.56Common StockSEC:0001209191-15-067363:0

25 of 28 declarations